A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
Clinical trial NCT00246090 · COMPLETED
Trial details
- NCT number
- NCT00246090
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-09-01
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.